Zimmer Biomet Holdings Overview
Zimmer Biomet Holdings Target Price
Analysts' average 12-month price target for Zimmer Biomet Holdings is $100.
Get informed when a big investor buys or sells
+ FollowShare Price
$98.07
Average Target Price
$104.33
6.4% upside
6.4% upside9 analysts in the last 4 months
High: $120 | Low: $93
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-08-10 | Canaccord GenuityCaitlin Cronin | $100 | 2% upside |  |
| 2026-08-06 | Truist Financial | $106 | 8.1% upside | |
| 2026-08-06 | Robert W. Baird | $104 | 6% upside | |
| 2026-08-06 | UBSPatrick Wood | $120 | 22.4% upside | |
| 2026-08-06 | Bernstein | $93 |  5.2% downside | |
| 2026-08-06 | BMO Capital | $96 | 2.1% downside | |
| 2026-08-06 | RBC CapitalKendall Au | $110 | 12.2% upside | |
| 2026-07-28 | UBSPatrick Wood | $115 | 17.3% upside | |
| 2026-07-08 | BMO Capital | $95 | 3.1% downside | |
| 2026-04-29 | Truist Financial | $92 | 6.2% downside | |
| 2026-04-29 | Canaccord Genuity | $83 | 15.4% downside | |
| 2026-04-29 | Stifel NicolausRick Wise | $105 | 7.1% upside | |
| 2026-04-29 | Robert W. Baird | $92 | 6.2% downside | |
| 2026-04-29 | BarclaysMatt Miksic | $94 | 4.2% downside | |
| 2026-02-12 | BarclaysMatt Miksic | $100 | 2% upside | |
| 2026-02-11 | UBS | $89 | 9.2% downside | |
| 2026-01-28 | UBS | $86 | 12.3% downside | |
| 2026-01-09 | Bernstein | $99 | 0.9% upside | |
| 2026-01-09 | Goldman SachsDavid Roman | $93 | 5.2% downside | |
| 2026-01-05 | Evercore ISI | $120 | 22.4% upside | |
| 2025-12-16 | Robert W. BairdJeff Johnson | $100 | 2% upside | |
| 2025-11-05 | Stifel NicolausRick Wise | $110 | 12.2% upside | |
| 2025-11-05 | Johnson Rice | $112 | 14.2% upside | |
| 2025-11-05 | Barclays | $105 | 7.1% upside | |
| 2025-10-13 | BTIGRyan Zimmerman | $122 | 24.4% upside | |
| 2025-10-10 | RBC Capital | $111 | 13.2% upside | |
| 2025-09-19 | Stifel Nicolaus | $118 | 20.3% upside | |
| 2025-09-18 | Redburn PartnersEd Ridley-Day | $130 | 32.6% upside | |
| 2025-08-08 | UBSDanielle Antalffy | $96 | 2.1% downside | |
| 2025-05-06 | Truist FinancialRichard Newitter | $101 | 3% upside | |
| 2025-05-06 | RBC CapitalShagun Singh | $112 | 14.2% upside | |
| 2025-05-06 | Stifel NicolausRick Wise | $115 | 17.3% upside | |
| 2025-05-05 | Wells FargoLarry Biegelsen | $98 | 0.1% downside | |
| 2024-10-31 | Truist FinancialRichard Newitter | $117 | 19.3% upside | |
| 2024-10-15 | OppenheimerSteven Lichtman | $135 | 37.7% upside | |
| 2024-10-03 | BTIGRyan Zimmerman | $126 | 28.5% upside | |
| 2024-10-01 | Evercore ISIVijay Kumar | $110 | 12.2% upside | |
| 2024-09-13 | Truist FinancialRichard Newitter | $112 | 14.2% upside | |
| 2024-09-10 | Canaccord GenuityCaitlin Cronin | $115 | 17.3% upside | |
| 2024-08-08 | Raymond JamesJayson Bedford | $128 | 30.5% upside | |
| 2024-08-08 | OppenheimerSteven Lichtman | $145 | 47.9% upside | |
| 2024-08-07 | Stifel NicolausRick Wise | $130 | 32.6% upside | |
| 2024-07-15 | Morgan StanleyDrew Ranieri | $120 | 22.4% upside | |
| 2024-07-01 | Piper SandlerMatt O'Brien | $115 | 17.3% upside | |
| 2024-05-31 | Piper SandlerMatthew O\'Brien | $140 | 42.8% upside | |
| 2024-05-30 | RBC CapitalShagun Singh | $140 | 42.8% upside | |
| 2024-05-28 | BTIGRyan Zimmerman | $139 | 41.7% upside | |
| 2024-05-21 | Argus ResearchDavid Toung | $150 | 53% upside | |
| 2023-02-06 | Truist Financial | $137 | 39.7% upside | |
| 2023-02-06 | Morgan Stanley | $140 | 42.8% upside | |